InsidersTradesSigma
Follow the Hansa Biopharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Hansa Biopharma AB has recorded 0 insider filings. Market capitalisation: €3.1bn. The full history is accessible without an account.
Analysts rate Hansa Biopharma AB Strong Buy (bullish), based on 8 analysts. Average price target: SEK 73.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Hansa Biopharma AB is a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. It is listed on the Stockholm Stock Exchange (XSTO).